KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Vertex Pharmaceuticals (VRTX) Non Operating Income (2016 - 2025)

Historic Non Operating Income for Vertex Pharmaceuticals (VRTX) over the last 14 years, with Q4 2025 value amounting to $6.5 million.

  • Vertex Pharmaceuticals' Non Operating Income rose 14362.42% to $6.5 million in Q4 2025 from the same period last year, while for Dec 2025 it was -$7.7 million, marking a year-over-year increase of 9105.69%. This contributed to the annual value of -$7.7 million for FY2025, which is 9105.69% up from last year.
  • Per Vertex Pharmaceuticals' latest filing, its Non Operating Income stood at $6.5 million for Q4 2025, which was up 14362.42% from -$9.8 million recorded in Q3 2025.
  • In the past 5 years, Vertex Pharmaceuticals' Non Operating Income ranged from a high of $42.4 million in Q3 2021 and a low of -$78.1 million during Q2 2022
  • Over the past 5 years, Vertex Pharmaceuticals' median Non Operating Income value was -$12.4 million (recorded in 2023), while the average stood at -$13.8 million.
  • Its Non Operating Income has fluctuated over the past 5 years, first plummeted by 250000.0% in 2024, then skyrocketed by 15714.29% in 2025.
  • Vertex Pharmaceuticals' Non Operating Income (Quarter) stood at $7.1 million in 2021, then plummeted by 538.03% to -$31.1 million in 2022, then skyrocketed by 68.49% to -$9.8 million in 2023, then tumbled by 52.04% to -$14.9 million in 2024, then soared by 143.62% to $6.5 million in 2025.
  • Its Non Operating Income was $6.5 million in Q4 2025, compared to -$9.8 million in Q3 2025 and $13.2 million in Q2 2025.